Social vulnerability is associated with post-operative morbidity following robotic-assisted lung resection
Highlight box
Key findings
• Patients’ sociodemographic status as measured by the social vulnerability index (SVI) is associated with increased likelihood of developing postoperative complications after lung resection.
What is known and what is new?
• SVI measures social disparity by incorporating 16 socioeconomic and demographic factors measured at the census tract level.
• We found that high SVI patients had significantly higher risk-adjusted odds of postoperative morbidity after lung resection compared to low SVI patients.
What is the implication, and what should change now?
• Recognition of vulnerability can aid in resource allocation in both the pre- and post-operative periods.
• Targeted interventions for these high-risk patients, like supplemented nutrition, mitigation of frailty through pre-habilitation and rehabilitation services, and improving communications and educational materials, may help to mitigate these effects.
• Efforts to allay disparities should also be implemented at levels that supersede individual patients in order to achieve more equitable surgical care.
Introduction
Pulmonary resection remains the mainstay of treatment for several pathologies, including early-stage non-small cell lung cancer, severe chronic obstructive pulmonary disease (COPD), diagnosis and treatment of pulmonary nodules, and tissue diagnosis of idiopathic pulmonary fibrosis. Despite improvements in perioperative management, transition to minimally invasive approaches including the rise of robotic-assisted thoracoscopic surgery (RATS) (1), and implementation of enhanced recovery after surgery (ERAS) protocols (2,3), pulmonary resection carries an associated short-term morbidity of 10–50% (4-6). Several studies have provided insight into risk factors associated with worse postoperative outcomes following pulmonary resection, including patient age, gender, body mass index (BMI), smoking status and comorbidities such as COPD (7-10). However sociodemographic factors, and their complex interactions and composite effects have yet to be comprehensively explored outside of access to care (11-13). If clinicians could ascertain which specific factors surrounding sociodemographic status are associated with poor post-operative outcomes, hospitals and providers could anticipate and mitigate these risk factors in order to achieve more equitable surgical care.
The social vulnerability index (SVI) is a metric generated by the Centers for Disease Control and Prevention (CDC) that uses 16 neighborhood-based variables to determine susceptibility to external stressors on human health (14). A summary of the variables is shown in Figure 1. Scores are updated every two years using census-tract level data and range from 0, indicating low vulnerability, to 100, indicating high vulnerability. SVI was initially designed to understand how a community might respond to natural or man-made disasters. However, several studies in the medical literature have linked high SVI (increased social vulnerability) to poor health outcomes at the patient level. Specific to surgery, high SVI has been associated with increased rates of postoperative adverse outcomes following major surgery, including colectomy (15) and esophagectomy (16), regardless of approach (open versus minimally invasive). However, a comprehensive analysis of 30-day postoperative outcomes following RATS lung resection has not been performed.
The purpose of this study was to determine if there was an association between sociodemographic status as measured by a patient’s SVI and odds of complications after robotic-assisted lung resection. We hypothesized that patients with high SVI would have significantly higher risk-adjusted odds of postoperative complications. These findings could help guide both inpatient planning and the perioperative allocation of resources for this potentially high-risk patient population. We present this article in accordance with the STROBE reporting checklist (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1122/rc).
Methods
Study design
The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the Colorado Multiple Institutional Review Board (COMIRB; IRB Organization No. IORG0000433) and individual consent for this retrospective analysis was waived. This was a retrospective cohort study at the University of Colorado Hospital between January 1, 2021, and November 30, 2022. The University of Colorado Hospital is a quaternary academic referral medical center linked with the University of Colorado School of Medicine. During the study period, there were four operative, board-certified thoracic surgeons who all perform lung resections using open, video-assisted thoracoscopic surgery (VATS) or RATS approaches based on patient factors. For the purposes of this study, all patients undergoing robotic-assisted lung resection (lobectomy, segmentectomy or wedge resection) were identified using current procedural terminology (CPT) codes and targeted for inclusion. Patients under 18 years old or whose home address were not documented in the electronic health record (EHR) or able to be geocoded were excluded. Patients’ demographic information including age, race/ethnicity, American Society of Anesthesiology physical classification (ASA class), BMI, medical comorbidities, SVI, operative data including surgical procedure performed, indication for surgery, laterality, and operative time (which includes robotic docking time), and rates of postoperative complications were obtained via manual EHR review.
Patients were grouped into low SVI (<75th percentile) and high SVI (≥75th percentile) cohorts, consistent with prior studies (15-18), using the CDC’s publicly available interactive SVI tool (https://svi.cdc.gov/map.html) at the census tract level. The primary outcome was 30-day overall postoperative complication, which was defined as the occurrence of any stroke, urinary tract infection, unexpected need for intensive care, readmission, unexpected emergency department (ED) visit, or any respiratory, cardiac, infectious, or renal complication. Secondary outcomes included individual 30-day outcomes, specifically length of stay, mortality, surgical site infection (SSI), postoperative pneumothorax or hemothorax, pleural effusion, pneumonia, need for therapeutic bronchoscopy or reintubation, prolonged ventilator use (>48 hours), prolonged air leak (>5 days), need for upgrade to intensive care status, need for tracheostomy, sepsis/septic shock, deep venous thrombosis (DVT) or pulmonary embolism (PE), arrythmia, cardiac arrest, stroke, conversion to open surgery, and post-discharge ED presentation. Complications were graded using Clavien-Dindo Classification System (19).
Statistical analysis
Bivariate analysis of demographic, perioperative variables and postoperative outcomes of patients with high SVI versus those with low SVI was conducted using the Chi-squared test and Fisher’s exact test for categorical variables, and the Wilcoxon-Mann-Whitney test for non-normally-distributed continuous variables, defined by the Shapiro-Wilk Test for Normality. Multivariable analysis evaluating primary and secondary outcomes that were statistically significantly different on bivariate analysis were conducted using a regression model that was adjusted for baseline patient variables including age, sex, race, ethnicity, ASA class, and procedure. All patients were included in multivariable models. Descriptive statistics are presented as absolute numbers and percentages for categorical variables. For continuous variables, statistics are presented as median and interquartile range (IQR). A two-sided P value of <0.05 was considered statistically significant. All analyses were performed using SPSS version 25 (IBM Corp., Armonk, NY, USA) and SAS version 9.4 (SAS Institute Inc., Cary, NC, USA).
Results
Patient characteristics
There were a total of 347 patients targeted for inclusion; of these, 27 (7.8%) were excluded due to inability to obtain SVI, leaving a total of 320 patients in the analytic cohort. In the study cohort, 40 patients (12.5%) were allocated to the high SVI group. A summary of patient demographics and medical history is shown in Table 1. The median (IQR) age was 67 (IQR, 60–73) years. The majority were women (63.1%), White (91.3%) and non-Hispanic (94.4%). Patients in the high SVI group were significantly more likely to be non-White (27.5% vs. 6.1%, P<0.001) and of Hispanic ethnicity (22.5% vs. 3.2%, P<0.001) than those in the low SVI group. Patients in the high SVI group were more likely to have COPD (15.0% vs. 5.7%, P=0.042), however there were no differences in the presence of other major comorbidities, ASA class or BMI (all P>0.05).
Table 1
Demographic characteristic | Low SVI (n=280) | High SVI (n=40) | All (n=320) | P value |
---|---|---|---|---|
Age (years) | 67 [60–73] | 68 [60–72] | 67 [60–73] | 0.966 |
Sex | 0.431 | |||
Male | 101 (36.1) | 17 (42.5) | 118 (36.9) | |
Female | 179 (63.9) | 23 (57.5) | 202 (63.1) | |
Race | <0.001* | |||
White | 263 (93.9) | 29 (72.5) | 292 (91.3) | |
Non-White | 17 (6.1) | 11 (27.5) | 28 (8.8) | |
Ethnicity | <0.001* | |||
Hispanic | 9 (3.2) | 9 (22.5) | 18 (5.6) | |
Non-Hispanic | 271 (96.8) | 31 (77.5) | 302 (94.4) | |
ASA class | 0.175 | |||
II | 54 (19.3) | 3 (7.5) | 57 (17.8) | |
III | 222 (79.3) | 36 (90.0) | 258 (80.6) | |
IV | 4 (1.4) | 1 (2.5) | 5 (1.6) | |
Comorbidities | ||||
Any comorbidity | 139 (49.6) | 25 (62.5) | 164 (51.3) | 0.128 |
Stroke or TIA | 9 (3.2) | 2 (5.0) | 11 (3.4) | 0.634 |
Hypertension | 104 (37.1) | 18 (45.0) | 122 (38.1) | 0.385 |
Coronary artery disease | 18 (6.4) | 3 (7.5) | 21 (6.6) | 0.735 |
Congestive heart failure | 3 (1.1) | 0 (0.0) | 3 (0.9) | >0.99 |
COPD | 16 (5.7) | 6 (15.0) | 22 (6.9) | 0.042* |
Diabetes mellitus | 30 (10.7) | 8 (20.0) | 38 (11.9) | 0.113 |
Chronic kidney disease | 17 (6.1) | 4 (10.0) | 21 (6.6) | 0.314 |
Liver disease | 8 (2.9) | 0 (0.0) | 8 (2.5) | 0.602 |
BMI (kg/m2) | 25.6 [22.3–29.6] | 25.1 [22.7–29.0] | 35.6 [22.3–29.4] | 0.866 |
Data are presented as median [interquartile range] or n (%). *, significant P values. SVI, social vulnerability index; ASA, American Society of Anesthesiologists; TIA, transient ischemic attack; COPD, chronic obstructive pulmonary disease; BMI, body mass index.
Operative characteristics
A summary of operative characteristics is shown in Table 2. The majority of operations performed were lobectomies (64.7%), followed by wedge resection (19.4%) and segmentectomies (15.9%). Operations were performed for the resection of a mass or nodule (75.6%), mycobacterium avium complex/nontuberculous mycobacteria (MAC/NTMB)-associated bronchiectasis (16.3%), interstitial lung disease (4.1%), bullous disease (2.2%) or bronchiectasis (1.9%). There were no differences in operative characteristics between groups.
Table 2
Operative characteristics | Low SVI (n=280) | High SVI (n=40) | All (n=320) | P value |
---|---|---|---|---|
Procedure | 0.112 | |||
RATS lobectomy | 179 (63.9) | 28 (70.0) | 207 (64.7) | |
RATS segmentectomy | 49 (17.5) | 2 (5.0) | 51 (15.9) | |
RATS wedge | 52 (18.6) | 10 (25.0) | 62 (19.4) | |
Indication | 0.423 | |||
Bronchiectasis | 5 (1.8) | 1 (2.5) | 6 (1.9) | |
Bullous disease | 7 (2.5) | 0 (0.0) | 7 (2.2) | |
Interstitial lung disease | 11 (3.9) | 2 (5.0) | 13 (4.1) | |
MAC/NTMB | 49 (17.5) | 3 (7.5) | 52 (16.3) | |
Mass/nodule | 208 (74.3) | 34 (85.0) | 242 (75.6) | |
Laterality | 0.293 | |||
Bilateral | 1 (0.4) | 0 (0.0) | 1 (0.3) | |
Left | 98 (35.0) | 19 (47.5) | 117 (36.6) | |
Right | 181 (64.6) | 21 (52.5) | 202 (63.1) | |
Case time (minutes) | 177 [133–230] | 183 [123–252] | 179 [133–236] | 0.237 |
Data are presented as median [interquartile range] or n (%). SVI, social vulnerability index; RATS, robotic-assisted thoracoscopic surgery; MAC/NTMB, mycobacterium avium complex/nontuberculous mycobacteria.
Outcomes
A summary of 30-day outcomes is shown in Table 3, with associated Clavien-Dindo classification. Overall morbidity was 26.9%, with the most frequent complication being prolonged air leak (11.3%) (of which none were discharged with portable drain), followed by unanticipated need for intensive care (5.9%) and superficial SSI (5.3%). On unadjusted analysis, high SVI was associated with increased rates of several complications including superficial SSI (12.5% vs. 4.3%, P=0.047), hemothorax (5.0% vs. 0.0%, P=0.015), unanticipated need for intensive care (15.0% vs. 4.6%, P=0.021), sepsis (10.0% vs. 1.1%, P=0.006), return to operating room (5.0% vs. 0.4%, P=0.042) and all cause morbidity (42.5% vs. 24.6%, P=0.017). There were no occurrences of reintubation, prolonged ventilator use, tracheostomy, DVT/PE, myocardial infarction or stoke in either group. Complications in the high SVI group trended towards increased severity on Clavien-Dindo classification, however this did not reach significance {2 [2–3] vs. 2 [1–3], P=0.186}. Following adjustment for preoperative variables, this finding of increased morbidity persisted [odds ratio (OR) =2.53; 95% confidence interval: 1.19–5.35; P=0.015]. Risk-adjusted predictors of overall morbidity are shown in Table 4, the only significant predictors were high SVI (compared to low SVI) and lobectomy (compared to wedge resection). Index length of stay was not significantly different between high and low SVI groups (P=0.434), similarly the rates of ED presentation and readmission were not significantly different (P=0.573 and P=1.00, respectively). Table S1 summarizes a sub-group analysis of outcomes by procedure.
Table 3
Outcome | Low SVI (n=280) | High SVI (n=40) | All (n=320) | P value |
---|---|---|---|---|
Index length of stay (days) | 3 [2–5] | 3 [2–6] | 3 [2–5] | 0.434 |
Superficial SSI | 12 (4.3) | 5 (12.5) | 17 (5.3) | 0.047* |
Clavien-Dindo grade II | 12 (100.0) | 5 (100.0) | 17 (100.0) | >0.99 |
Deep SSI | 1 (0.4) | 0 (0.0) | 1 (0.3) | >0.99 |
Clavien-Dindo grade II | 1 (100.0) | – | 1 (100.0) | – |
Pneumothorax | 12 (4.3) | 3 (7.5) | 15 (4.7) | 0.414 |
Clavien-Dindo grade III | 12 (100.0) | 3 (100.0) | 15 (100.0) | >0.99 |
Hemothorax | 0 (0.0) | 2 (5.0) | 2 (0.6) | 0.015* |
Clavien-Dindo grade III | – | 2 (100.0) | 2 (100.0) | – |
Pleural effusion | 3 (1.1) | 0 (0.0) | 3 (0.9) | >0.99 |
Clavien-Dindo grade III | 3 (100.0) | – | 3 (100.0) | – |
Pneumonia | 6 (2.1) | 1 (2.5) | 7 (2.2) | >0.99 |
Clavien-Dindo grade II | 6 (100.0) | 1 (100.0) | 7 (100.0) | >0.99 |
Prolonged air leak | 30 (10.7) | 6 (15.0) | 36 (11.3) | 0.423 |
Clavien-Dindo grade I | 23 (76.7) | 3 (50.0) | 26 (72.2) | 0.317 |
Clavien-Dindo grade III | 7 (23.3) | 3 (50.0) | 10 (27.8) | |
ICU upgrade | 13 (4.6) | 6 (15.0) | 19 (5.9) | 0.021* |
Clavien-Dindo grade II | 9 (69.2) | 3 (50.0) | 12 (63.2) | 0.873 |
Clavien-Dindo grade III | 2 (15.4) | 1 (16.7) | 3 (15.8) | – |
Clavien-Dindo grade IV | 2 (15.4) | 2 (33.3) | 4 (21.1) | – |
Sepsis | 3 (1.1) | 4 (10.0) | 7 (2.2) | 0.006* |
Clavien-Dindo grade II | 1 (33.3) | 3 (75.0) | 4 (57.1) | 0.486 |
Clavien-Dindo grade IV | 2 (66.7) | 1 (25.0) | 3 (42.9) | – |
Septic shock | 2 (0.7) | 1 (2.5) | 3 (0.9) | 0.331 |
Clavien-Dindo grade IV | 2 (100.0) | 1 (100.0) | 3 (100.0) | >0.99 |
Arrythmia | 11 (3.9) | 3 (7.5) | 14 (4.4) | 0.396 |
Clavien-Dindo grade II | 11 (100.0) | 3 (100.0) | 14 (100.0) | >0.99 |
Cardiac arrest | 1 (0.4) | 0 (0.0) | 1 (0.3) | >0.99 |
Clavien-Dindo grade IV | 1 (100.0) | – | 1 (100.0) | – |
Chest tube reinsertion | 18 (6.4) | 5 (12.5) | 23 (7.2) | 0.185 |
Therapeutic bronchoscopy | 3 (1.1) | 1 (2.5) | 4 (1.3) | 0.415 |
Conversion to open | 4 (1.4) | 2 (5.0) | 6 (1.9) | 0.165 |
Return to operating room | 1 (0.4) | 2 (5.0) | 3 (0.9) | 0.042* |
Any complication | 69 (24.6) | 17 (42.5) | 86 (26.9) | 0.017* |
Highest Clavien-Dindo grade | 2 [1–3] | 2 [2–3] | 2 [2–3] | 0.186 |
ED presentation | 27 (9.6) | 5 (12.5) | 32 (10.0) | 0.573 |
Readmission | 21 (7.5) | 3 (7.5) | 24 (7.5) | >0.99 |
30-day mortality | 0 (0.0) | 0 (0.0) | 0 (0.0) | – |
Data are presented as median [interquartile range] or n (%). *, significant P values. SVI, social vulnerability index; SSI, surgical site infection; ICU, intensive care unit; ED, emergency department.
Table 4
Predictor variable | Odds ratio (95% confidence interval) |
---|---|
Increasing age | 1.00 (0.98–1.02) |
Male vs. female sex | 0.94 (0.55–1.59) |
Non-Hispanic vs. Hispanic ethnicity | 0.75 (0.25–2.20) |
White vs. non-White race | 1.15 (0.46–2.88) |
ASA 4 vs. ASA 2 | 0.74 (0.07–7.81) |
ASA 4 vs. ASA 3 | 0.66 (0.07–6.54) |
Wedge vs. lobectomy | 0.47 (0.32–0.99)* |
Wedge vs. segmentectomy | 0.49 (0.19–1.23) |
High SVI vs. low SVI | 2.53 (1.19–5.35)* |
*, significant predictors. ASA, American Society of Anesthesiologists; SVI, social vulnerability index.
Discussion
In a single-institution retrospective cohort study, we showed that patients undergoing robotic-assisted lung resection with high SVI have significantly higher odds of 30-day postoperative complications than patients who had lower SVI, including overall morbidity, superficial SSI, postoperative hemothorax, intensive care need, postoperative sepsis, and unplanned reoperation. Highly vulnerable patients remained significantly more likely to experience any 30-day complication after risk-adjustment for perioperative confounders. These findings show that patient sociodemographic status beyond race or socioeconomic status is an independent contributor to poor postoperative outcomes. Interestingly, despite increased complications, we did not note an associated significant difference in hospital length of stay between high and low SVI groups.
Social vulnerability arises from complex political, social and economic structures and resultantly is discussed frequently in the context of ecological models (20). However, there has been growing interest in applying the concept of social vulnerability in the health care setting. In this context, social vulnerability can be defined as the degree to which a persons’ overall social circumstances leave them susceptible to further insults, including health adverse events (21). At present, SVI has been identified as an important factor associated with increased risk of postoperative adverse outcomes and 30-day mortality following major surgery, including specific demonstration in colectomy (15) and esophagectomy (16) patients. Two prior studies by Diaz et al. (22) and Hyer et al. (23) both performed subgroup analyses on patients who underwent lung resection among a larger cohort of other major surgeries and demonstrated that patients with high SVI patients had increased rates of post-operative complications. In a follow up study of lung and colon resection only groups, Diaz et al. again reported similar results demonstrating the independent association of social vulnerability and postoperative outcomes, with an effect compounded by residential diversity (24). Notably, in these studies it is not clear the surgical approach, and whether these cohorts included minimally invasive techniques. Our data supports, and confirms these prior findings and builds upon them by demonstrating the specific complications affected by socioeconomic status while using more discrete census-tract level information rather than county level data, while focusing on the RATS approach which is reflective of the modern era of thoracic surgery.
Living under vulnerable conditions, for example social or physical isolation, insecure housing or a high income-to-debt ratio may induce a chronic stress state which blunts a patients’ ability to respond to health stressors including surgical stress. At baseline, all patients experience a surgical stress response, which is a well-documented metabolic phenomenon induced by activation of neuroendocrine pathways and inflammatory mediators (25). Patients who have inadequate reserve, such as those highly vulnerable patients living in a state of chronic stress might be unable to respond to these metabolic derangements. Emerging literature suggests that psychological perioperative factors including a patient’s psychologic state or personality may directly affect the surgical stress response (26) and that these factors can predict postoperative outcomes with accuracy similar to models using surgical and anesthetic variables (25).
We believe that a patient’s SVI might serve as a surrogate for how they will respond to surgical stress and that SVI can be used to guide targeted interventions to mitigate the dysregulation. Preoperatively, SVI could be incorporated into risk stratification. While it is quick to lookup a patient’s score manually, SVI could conceivably be written into code in the EHR for automated generation in preoperative clinical visits, and could function similar to other preoperative risk calculators, such as the American College of Surgeons National Surgical Quality Improvement Program’s (ACS-NSQIP) Surgical Risk Calculator (27) and the Surgical Risk Preoperative Assessment System (SURPAS) (28). There have been mixed effects on how incorporating a measure of social vulnerability like the SVI affects the predictive modeling of these risk calculators, with some studies suggesting that it improves prediction (29) and others suggesting that the predictor models are not significantly improved by including a socially derived predictor variable (30). SVI could also aid in development of ERAS protocols (2,3), established bundles of proven interventions and post-operative care. Opportunity exists to incorporate SVI as a branch point in determining an automatic referral to a vulnerability-targeted set of discharge services including nutritional and physical therapy rehabilitation services.
Nutritional and pre-habilitation services, among other interventions, could mitigate the deleterious effects of social vulnerability. Social vulnerability has been associated with food insecurity (31), which has been linked to increased risk of readmission following major surgery (32,33). Similarly, extremes of BMI (<18.5 or ≥40 kg/m2) being linked to higher rates of complications (34,35). This finding is likely mediated through post-operative dysregulation of metabolic pathways that control the absorption of nutrients and subsequent break down leads to generation of energy. As such nutritional status has been identified as potentially modifiable risk factors in patients undergoing surgical treatment. At present, our institution supports universal nutritional optimization prior to anatomic lung resection including providing all patients with an immunonutrition supplement prior to their surgery. However, knowledge of a patient’s SVI score could be used for targeted vulnerability-level nutritional interventions including referral to perioperative nutritional services for assessment and intervention. Future studies would be required to determine the efficacy of these interventions on reducing inequities in surgical outcomes.
Since social vulnerability has also been correlated with frailty (36), targeted interventions might focus on perioperative rehabilitation services. It has been well established that rehabilitation following surgery can reduce complications and improves postoperative and functional outcomes. However, surgery-related rehabilitation is rarely actually recognized as an essential part of the continuum of care (37). Beyond post-operative rehabilitation, another emerging idea is pre-habilitation prior to surgery. This has been shown to optimize health outcomes (38), including improving functional capacity (39) and reducing complications in high risk patients (40). Specific to thoracic surgery, pre-habilitation has been shown to prevent functional decline (41) and be as effective as post-operative rehabilitation in returning to functional baseline (42). Improving referral to these services based on SVI scores could be beneficial to patients and reduce postoperative morbidity.
Finally, health literacy is a domain for targeted intervention based on SVI. It has been estimated that over 90 million Americans have inadequate health literacy (43) contributing to inability to understand basic instructions and make appropriate health related decisions (44). Health literacy is critical in the perioperative period, and misinterpretation or misunderstanding of complex preoperative and postoperative instructions can result in negative outcomes (45). Patients with high SVI, which may serve as surrogate marker for low health literacy may benefit from additional time and resources during discharge teaching, including management of incisions or wounds, surgically placed drains, and recognition of potential complications warranting in-person medical evaluation. Increased education efforts in conjunction with arrangement of any necessary home-health need may limit the general anxiety of self-care during recovery from surgery.
There are several important limitations to consider when interpreting the results of the study. Firstly, the single institution and retrospective nature of this study may limit its generalizability to other institutions, patient populations, or geographical regions. Secondly, the study included a relatively small cohort of patients in the high SVI cohort, which may have limited the power to detect differences in the occurrence of more rare postoperative complication. We also hypothesize limited sample size contributes to our observation that despite increased complications in the high SVI group, length of stay did not significantly differ. Given that RATS surgery has relatively short length of stay at baseline, a large sample would be needed to detect differences. Similarly, the small sample size limited our ability to generate risk-adjusted odds ratios for individual complications as the observed rates of these complications did not meet the minimum of 10 outcome events per predictor variable required for appropriate analysis. Sample size was likely limited by our decision to include only RATS lung resections in analysis, however we elected to exclude open and VATS approaches to eliminate the bias of approach as prior studies have demonstrated significant differences in morbidity and mortality by approach, specifically RATS versus open (46), and we feel that focusing on this approach is reflective of the current trend in increase of RATS utilization as a minimally invasive approach to lung resection when compared to VATS (1). Our sample size was able to be increased by the inclusion of RATS wedge resections, which we elected to include due to the fact that the vast majority of our RATS wedge resections are performed for malignant indications. Finally, there was no evaluation of what specific aspect associated with high SVI confers the increased risk of postoperative complications, which makes the efficacy surrounding potential interventions to mitigate these findings speculative. Prior studies have suggested that poor access to medical care or distance to hospital may be contributory, but the study institution is surrounded by areas with high SVI scores in close proximity, which limits our ability to test this hypothesis. Additionally, it should be recognized that we did note an increased rate of COPD in our highly vulnerable population which may have contributed to the observe outcomes despite risk-adjustment for comorbidities.
Conclusions
In conclusion, high SVI was associated with increased odds of postoperative complications after robotic-assisted lung resection even after risk-adjustment for perioperative variables. This high-risk patient population merits significant consideration during the surgical planning for robotic lung resection. Recognition of vulnerability can aid in resource allocation in both the pre- and postoperative periods in an effort to reduce these observed complications. Targeted interventions for these high-risk patients, like supplemented nutrition, mitigation of frailty through pre-habilitation and rehabilitation services, and improving communications and educational materials, may help to mitigate these effects. Efforts to allay disparities should also be implemented at levels that supersede individual patients in order to achieve more equitable surgical care. Future studies should be directed towards elucidating the specific factors of SVI that drive this increase in complication rates so that targeted resources can be directed to this high-risk population to mitigate their risk of complications.
Acknowledgments
Funding: This work was supported, in part, by the National Institutes of Health, under Ruth L. Kirschstein National Research Service Award T32CA17468. This presentation’s contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.
Footnote
Reporting Checklist: The authors have completed the STROBE reporting checklist. Available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1122/rc
Data Sharing Statement: Available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1122/dss
Peer Review File: Available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1122/prf
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-23-1122/coif). C.M.S. reports that she receives associated grant funding from the National Institutes of Health, under Ruth L. Kirschstein National Research Service Award T32CA17468. J.D.M. reports that he performs consulting for Intuitive Surgical, Inc. R.A.M. reports that he consults for Medtronic, Inc. The other authors have no conflicts of interest to declare.
Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by the Colorado Multiple Institutional Review Board (COMIRB; IRB Organization No. IORG0000433) and individual consent for this retrospective analysis was waived.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Alwatari Y, Khoraki J, Wolfe LG, et al. Trends of utilization and perioperative outcomes of robotic and video-assisted thoracoscopic surgery in patients with lung cancer undergoing minimally invasive resection in the United States. JTCVS Open 2022;12:385-98. [Crossref] [PubMed]
- Dyas AR, Kelleher AD, Erickson CJ, et al. Development of a universal thoracic enhanced recover after surgery protocol for implementation across a diverse multi-hospital health system. J Thorac Dis 2022;14:2855-63. [Crossref] [PubMed]
- Batchelor TJP, Rasburn NJ, Abdelnour-Berchtold E, et al. Guidelines for enhanced recovery after lung surgery: recommendations of the Enhanced Recovery After Surgery (ERAS®) Society and the European Society of Thoracic Surgeons (ESTS). Eur J Cardiothorac Surg 2019;55:91-115. [Crossref] [PubMed]
- Kneuertz PJ, Singer E, D'Souza DM, et al. Postoperative complications decrease the cost-effectiveness of robotic-assisted lobectomy. Surgery 2019;165:455-60. [Crossref] [PubMed]
- Berry MF, Hanna J, Tong BC, et al. Risk factors for morbidity after lobectomy for lung cancer in elderly patients. Ann Thorac Surg 2009;88:1093-9. [Crossref] [PubMed]
- Ziarnik E, Grogan EL. Postlobectomy Early Complications. Thorac Surg Clin 2015;25:355-64. [Crossref] [PubMed]
- Gupta H, Ramanan B, Gupta PK, et al. Impact of COPD on postoperative outcomes: results from a national database. Chest 2013;143:1599-606. [Crossref] [PubMed]
- Lugg ST, Agostini PJ, Tikka T, et al. Long-term impact of developing a postoperative pulmonary complication after lung surgery. Thorax 2016;71:171-6. [Crossref] [PubMed]
- Sekine Y, Suzuki H, Yamada Y, et al. Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection. Thorac Cardiovasc Surg 2013;61:124-30. [Crossref] [PubMed]
- Yang R, Wu Y, Yao L, et al. Risk factors of postoperative pulmonary complications after minimally invasive anatomic resection for lung cancer. Ther Clin Risk Manag 2019;15:223-31. [Crossref] [PubMed]
- Harrison S, Judd J, Chin S, et al. Disparities in Lung Cancer Treatment. Curr Oncol Rep 2022;24:241-8. [Crossref] [PubMed]
- Loehrer AP, Chen L, Wang Q, et al. Rural Disparities in Lung Cancer-directed Surgery: A Medicare Cohort Study. Ann Surg 2023;277:e657-63. [Crossref] [PubMed]
- Randhawa SK, Roberts SH, Puri V. Disparities in Lung Transplantation. Thorac Surg Clin 2022;32:51-5. [Crossref] [PubMed]
- ATSDR. AfTSaDR. CDC’s Social Vulnerability Index (CVI) 2022. Available online: https://www.atsdr.cdc.gov/placeandhealth/svi/index.html
- Carmichael H, Dyas AR, Bronsert MR, et al. Social vulnerability is associated with increased morbidity following colorectal surgery. Am J Surg 2022;224:100-5. [Crossref] [PubMed]
- Stuart CM, Dyas AR, Byers S, et al. Social vulnerability is associated with increased postoperative morbidity following esophagectomy. J Thorac Cardiovasc Surg 2023;166:1254-61. [Crossref] [PubMed]
- Diaz A, Barmash E, Azap R, et al. Association of County-Level Social Vulnerability with Elective Versus Non-elective Colorectal Surgery. J Gastrointest Surg 2021;25:786-94. [Crossref] [PubMed]
- Azap RA, Hyer JM, Diaz A, et al. Association of County-Level Vulnerability, Patient-Level Race/Ethnicity, and Receipt of Surgery for Early-Stage Hepatocellular Carcinoma. JAMA Surg 2021;156:197-9. [Crossref] [PubMed]
- Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-96. [Crossref] [PubMed]
- Andrew MK, Keefe JM. Social vulnerability from a social ecology perspective: a cohort study of older adults from the National Population Health Survey of Canada. BMC Geriatr 2014;14:90. [Crossref] [PubMed]
- Mah J, Rockwood K, Stevens S, et al. Do Interventions Reducing Social Vulnerability Improve Health in Community Dwelling Older Adults? A Systematic Review. Clin Interv Aging 2022;17:447-65. [Crossref] [PubMed]
- Diaz A, Hyer JM, Barmash E, et al. County-level Social Vulnerability is Associated With Worse Surgical Outcomes Especially Among Minority Patients. Ann Surg 2021;274:881-91. [Crossref] [PubMed]
- Hyer JM, Tsilimigras DI, Diaz A, et al. High Social Vulnerability and "Textbook Outcomes" after Cancer Operation. J Am Coll Surg 2021;232:351-9. [Crossref] [PubMed]
- Diaz A, Dalmacy D, Hyer JM, et al. Intersection of social vulnerability and residential diversity: Postoperative outcomes following resection of lung and colon cancer. J Surg Oncol 2021;124:886-93. [Crossref] [PubMed]
- Lanini I, Amass T, Calabrisotto CS, et al. The influence of psychological interventions on surgical outcomes: a systematic review. J Anesth Analg Crit Care 2022;2:31. [Crossref] [PubMed]
- Mavros MN, Athanasiou S, Gkegkes ID, et al. Do psychological variables affect early surgical recovery? PLoS One 2011;6:e20306. [Crossref] [PubMed]
- Bilimoria KY, Liu Y, Paruch JL, et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg 2013;217:833-42.e1-3.
- Meguid RA, Bronsert MR, Juarez-Colunga E, et al. Surgical Risk Preoperative Assessment System (SURPAS): III. Accurate Preoperative Prediction of 8 Adverse Outcomes Using 8 Predictor Variables. Ann Surg 2016;264:23-31. [Crossref] [PubMed]
- Mehaffey JH, Hawkins RB, Charles EJ, et al. Socioeconomic "Distressed Communities Index" Improves Surgical Risk-adjustment. Ann Surg 2020;271:470-4. [Crossref] [PubMed]
- Dyas AR, Carmichael H, Bronsert MR, et al. Does Adding a Measure of Social Vulnerability to a Surgical Risk Calculator Improve Its Performance? J Am Coll Surg 2022;234:1137-46. [Crossref] [PubMed]
- Mtintsilana A, Dlamini SN, Mapanga W, et al. Social vulnerability and its association with food insecurity in the South African population: findings from a National Survey. J Public Health Policy 2022;43:575-92. [Crossref] [PubMed]
- Dutko P, Ver Ploeg M, Farrigan T. Characteristics and influential factors of food deserts: United States Department of Agriculture; 2012. Available online: https://www.ers.usda.gov/webdocs/publications/45014/30940_err140.pdf
- Phillips JD, Fay KA, Wakeam E, et al. Food Deserts Increase Readmission After Esophagectomy for Cancer: A Multi-institutional Study. Ann Thorac Surg 2023;116:246-53. [Crossref] [PubMed]
- Tjeertes EK, Hoeks SE, Beks SB, et al. Obesity--a risk factor for postoperative complications in general surgery? BMC Anesthesiol 2015;15:112. [Crossref] [PubMed]
- Chen HN, Chen XZ, Zhang WH, et al. The Impact of Body Mass Index on the Surgical Outcomes of Patients With Gastric Cancer: A 10-Year, Single-Institution Cohort Study. Medicine (Baltimore) 2015;94:e1769. [Crossref] [PubMed]
- Andrew MK, Mitnitski AB, Rockwood K. Social vulnerability, frailty and mortality in elderly people. PLoS One 2008;3:e2232. [Crossref] [PubMed]
- Barth CA, Wladis A, Roy N, et al. Ways to improve surgical outcomes in low- and middle-income countries. Bull World Health Organ 2022;100:726-32. [Crossref] [PubMed]
- Barberan-Garcia A, Ubré M, Roca J, et al. Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial. Ann Surg 2018;267:50-6. [Crossref] [PubMed]
- Minnella EM, Awasthi R, Loiselle SE, et al. Effect of Exercise and Nutrition Prehabilitation on Functional Capacity in Esophagogastric Cancer Surgery: A Randomized Clinical Trial. JAMA Surg 2018;153:1081-9. [Crossref] [PubMed]
- Berkel AEM, Bongers BC, Kotte H, et al. Effects of Community-based Exercise Prehabilitation for Patients Scheduled for Colorectal Surgery With High Risk for Postoperative Complications: Results of a Randomized Clinical Trial. Ann Surg 2022;275:e299-306. [Crossref] [PubMed]
- Sebio García R, Yáñez-Brage MI, Giménez Moolhuyzen E, et al. Preoperative exercise training prevents functional decline after lung resection surgery: a randomized, single-blind controlled trial. Clin Rehabil 2017;31:1057-67. [Crossref] [PubMed]
- Ferreira V, Minnella EM, Awasthi R, et al. Multimodal Prehabilitation for Lung Cancer Surgery: A Randomized Controlled Trial. Ann Thorac Surg 2021;112:1600-8. [Crossref] [PubMed]
- Wolf MS, Davis TC, Shrank W, et al. To err is human: patient misinterpretations of prescription drug label instructions. Patient Educ Couns 2007;67:293-300. [Crossref] [PubMed]
- Smith SG, Curtis LM, Wardle J, et al. Skill set or mind set? Associations between health literacy, patient activation and health. PLoS One 2013;8:e74373. [Crossref] [PubMed]
- De Oliveira GS Jr, McCarthy RJ, Wolf MS, et al. The impact of health literacy in the care of surgical patients: a qualitative systematic review. BMC Surg 2015;15:86. [Crossref] [PubMed]
- Zhang L, Gao S. Robot-assisted thoracic surgery versus open thoracic surgery for lung cancer: a system review and meta-analysis. Int J Clin Exp Med 2015;8:17804-10.